ARDX. Thanks for the comments Tony . Not surprised Akebia / KERX are not selling much. Wife's patients don't like the drug mainly due to pill burden ( up to 12 tabs a day with meals ) , complaints on hard black stool and constipation . She also mentioned briefly issue with monitoring for iron .
So with Auryxia ...adherence is poor . Pill burden high .
ARDX's drug is 2 small pills a day and you dont need to take with meals .
Are U or anyone else here following the OMER and KDNY P 3 IgA Nephropathy trials with 2023 readouts ? Currently 2 IgA drugs recently approved ...both very expensive , one with a boxed warning . May write a post on them later Kiwi
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.